The administration named lobbying, then softened the language
The White House's May 2025 MAHA Report did not treat chemical lobbying as a fringe complaint. It said the chemical-manufacturing industry spent roughly $77 million on federal lobbying in 2024 and said 60 percent of chemical-sector lobbyists previously held federal posts.
The September 2025 MAHA Strategy still talks about chemicals and pesticides, but the tone changes. The later document leans harder on review process, cumulative-exposure research, and precision application than on the political force that shaped the system.
Dicamba is the clearest access trail in the file
A March 11, 2025 email archived by ToxicDocs shows then-American Soybean Association official Kyle Kunkler asking Nancy Beck for a virtual dicamba meeting. The same document shows Beck replying the same day that EPA would ask the team to set it up.
EPA's public timeline shows the agency proposed registration for three dicamba products on July 23, 2025 and approved three dicamba herbicide products on February 6, 2026. EPA says the approval includes heightened dicamba protections and that it found no unreasonable risk when the products are used according to label directions.
The personnel overlap is visible without any theory
EPA's current Office of Chemical Safety and Pollution Prevention leadership page lists Nancy Beck, Lynn Dekleva, and Kyle Kunkler in top roles inside the office that oversees pesticides and toxic chemicals.
The names sit on the org chart. The office regulating pesticides is staffed in part by people whose prior institutional ties already belong in the reporting frame.
Recusal paperwork is where the revolving door stops being abstract
Kunkler's EPA ethics file makes the revolving-door point concrete. In August 2025, EPA's ethics office wrote that his recusal obligations covered the American Soybean Association, his former employer, and 26 state soybean affiliates.
The federal ethics record documents the proximity of his prior institutional ties to the pesticide-regulation office.
Glyphosate turned influence into a live liability fight
On February 18, 2026, President Trump signed an executive order using Defense Production Act authority to support elemental phosphorus and glyphosate-based herbicides. The order also conferred the immunity available under section 707 of that law.
Two days later, H.R. 7601, the No Immunity for Glyphosate Act, was introduced in the House. The immediate dispute was whether chemical manufacturers should receive liability protection under that order.
The MAHA language sets the standard for what followed
Once the White House itself says chemical lobbying helped shape the public-health landscape, the later staffing, access, and regulatory posture have to be measured against that warning.
So far, the public file points in the other direction. It looks less like an industry pushed out of the room than like an industry still negotiating from inside it.
